Sigma Healthcare Ltd stock (AU000000SIG5): shares pause after Chemist Warehouse merger approval rally

Sigma Healthcare Ltd shares on the ASX were little changed on 05/29/2026 after a sharp rally earlier this month, as investors continued to digest the implications of the approved Chemist Warehouse reverse-merger and the company’s latest trading update in Australia.

Sigma Healthcare Ltd shares on the Australian Securities Exchange (ASX: SIG) traded broadly flat around AUD 2.85 on 05/29/2026, consolidating gains after a strong run earlier in May that followed regulatory approval for its transformational Chemist Warehouse transaction in Australia, according to ASX data as of 05/29/2026.

The stock, which is part of the Australian pharmaceuticals and healthcare distribution universe, had previously surged by close to 40% on the day the Australian Competition and Consumer Commission (ACCC) cleared the Chemist Warehouse reverse-merger proposal, as reported by Australian financial media on 05/16/2026.

This price consolidation comes as domestic investors reassess how the combined entity could reshape the pharmacy and wholesale distribution landscape in Australia, while also considering integration risks and the impact on Sigma’s capital structure and future earnings profile.

Market participants on the ASX are focusing on how management intends to execute on planned synergies from the Chemist Warehouse deal, including logistics optimization and purchasing scale benefits, alongside potential changes in store network strategy and branding in Sigma’s home market of Australia.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Sigma
• Sector/industry: Pharmaceutical wholesaling and retail pharmacy
• Headquarters/country: Clayton, Australia
• Core markets: Australian prescription, over-the-counter, and pharmacy retail markets
• Key revenue drivers: Wholesale distribution of medicines and health products to pharmacies, franchise and banner pharmacy networks, and related logistics services
• Home exchange/listing venue: ASX (SIG)
• Trading currency: AUD

Sigma Healthcare Ltd: core business model

Sigma Healthcare Ltd operates primarily as a national pharmaceutical wholesaler and pharmacy network operator in Australia, generating most of its revenue from supplying medicines and health products to community pharmacies while also earning fees from franchise, banner, and logistics services.

Valuation metrics and multiples for Sigma Healthcare Ltd

On 05/29/2026, Sigma Healthcare Ltd’s share price near AUD 2.85 on the ASX implied a market capitalization in the mid-single-digit billions of Australian dollars, based on an enlarged share count that incorporates the agreed terms of the Chemist Warehouse reverse-merger, according to ASX trading data and company deal documentation released in mid-May 2026.

Using the most recent full-year financial information available before the Chemist Warehouse combination, Sigma had been trading on a forward price-to-earnings multiple in the high-teens to low-twenties range and an enterprise-value-to-EBITDA multiple in the low-teens, based on Australian broker estimates published during April and May 2026, while the indicated dividend yield remained modest as the company prioritized balance-sheet flexibility and integration of the pending retail pharmacy asset base.

Conclusion

The subdued share price action of Sigma Healthcare Ltd on 05/29/2026 contrasts with the sharp move seen after the Chemist Warehouse merger approval, as the ASX market absorbs the valuation implications of the enlarged group.

Investors are weighing the company’s updated multiples and capital allocation plans against the potential benefits of higher scale in Australia’s pharmacy market, while also considering execution and integration risks associated with such a sizeable strategic transaction.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.